We’ve all seen the movie: tons of hand-to-hand combat, enemy soldiers lurking behind every wall. Now place that movie in your bloodstream and imagine…
The tangled amyloid and tau proteins that accumulate in the aging brains of people with Alzheimer’s have been a major focus for drug developers…
Scientists have largely focused on the buildup of beta-amyloid as one of the major drivers of Alzheimer’s disease, but more and more research is…
As research into Alzheimer’s advances, scientists are shifting their focus from beta-amyloid accumulation to inflammation as a main driver of the disease. In a…
In 2015, drug manufacturer Pfizer discovered that their drug Enbrel (etanercept), an anti-inflammatory used to treat rheumatoid arthritis, appeared to lower the risk of…
Previous evidence that Alzheimer’s could be prevented with an over-the-counter anti-inflammatory drug like Aspirin was refuted by a new study. Researchers have long known…
It hasn’t been a great year for Alzheimer’s drugs—or really a great decade, even. The most recent Phase 3 trial cancellation was a study…
Follow us